Friday, 8 June 2018

Investigation into NHS spending on generic medicines in primary care

Investigation into NHS spending on generic medicines in primary care During 2017, the prices of certain ‘generic’ medicines purchased by pharmacies for the NHS increased unexpectedly, placing what NHS England described as a “significant unbudgeted pressure” on clinical commissioning groups (CCGs).

Today’s investigation by the National Audit Office (NAO) sets out the possible causes of the price increases from 2017-18 and how the Department of Health and Social Care and NHS England responded in order to maintain the supply of generic medicines for patients and manage spending. The NAO has examined price increases that affected certain ‘generic’ medicines, as opposed to ‘branded’ medicines that are sold under the name given by the company that made them.

See also:

No comments:

Post a comment